#$%^&*AU2018101357A420181018.pdf#####Abstract The invention relates to pharmaceutical compositions comprising cannabidiol (CBD) and A 9-tetrahydrocannabinol (THC), and their use in the treatment of autism. The invention also relates to methods for treating autism.